Highlights

  • Synlait Milk (ASX:SM1) reported FY26 revenue of $1.94 billion and an underlying EBITDA of $46.3 million.
  • The reported net loss after tax was $75.4 million, while the second half recorded net profit after tax of $5.2 million.
  • Net debt stood at $215.0 million, and reporting will move to a 31 December balance date.
  • The annual meeting is scheduled for 4 December 2026, with director nominations closing on 3 November.

Synlait Milk is a New Zealand dairy company that makes nutritional formulas, functional dairy ingredients and specialty milks, with its main site at Dunsandel in Canterbury. The company reported its FY26 result in late September 2026, showing a full-year loss but a return to profit in the second half, and announced a change to its balance date.

Company Business

Synlait Milk (ASX:SM1) processes raw milk into infant and nutritional formulas, milk powders, liquid milk and cream. Its reported channels are Advanced Nutritionals, Ingredients, Foodservice and Consumer. The Dunsandel site includes milk powder dryers, an infant formula facility and a liquid milk plant.

The company collects more than 800 million litres of milk a year and exports to more than 50 markets. Customers include The a2 Milk Company, which has begun insourcing English label a2 Platinum production from Synlait, with the transition planned for the first half of its FY27.

Recent Development

In late August 2026 Synlait issued a performance update ahead of its full-year result, guiding to a reported net loss after tax of $70 million to $75 million. Acting Chief Executive Leon Fung said the results would show improvement but remain a long way from where the company wants them to be. The preliminary figures were subject to audit and impairment testing.

The full-year result followed in late September 2026 under the heading of operational recovery. The company said a return to operational stability flowed through to improved financial performance in the second half. It also confirmed that its reporting year-end will move from 31 July to 31 December. A transitional period, TP26, will run for five months from 1 August to 31 December 2026, and FY27 will cover 1 January to 31 December 2027.

In March 2026 Synlait reported changes agreed with its lenders, including a postponed reduction in one revolving credit facility, a waived minimum EBITDA test for the half year to 31 January 2026 and a suspended net senior leverage test for the 31 July 2026 balance date. At the half-year stage the company also withdrew FY26 financial guidance.

Financial Performance and Sector Context

For the year ended 31 July 2026, revenue was $1.94 billion and gross profit was $37.7 million. Reported EBITDA was $8.1 million and underlying EBITDA was $46.3 million. The reported net loss after tax was $75.4 million, while the underlying net loss after tax was $21.6 million. Net debt was $215.0 million, compared with $472.1 million at the end of the first half.

The half-year split shows the shape of the recovery. The first half recorded a reported EBITDA loss of $34.7 million and a net loss after tax of $80.6 million, with first-half revenue of $949 million. The second half delivered reported EBITDA of $42.8 million and net profit after tax of $5.2 million.

Sector context centres on dairy processing economics, where farmgate milk prices set the cost of the main input. The company noted that results may be affected by the timing of production and sales, working capital and seasonal factors.

For the five-month transitional period, the company is not providing quantitative earnings guidance, citing the short and non-comparable period. Stated priorities include operational and quality excellence and optimising product and customer mix.

Risks to Consider

Customer concentration and changes in customer sourcing, including the a2 Milk Company transition, can affect volumes. Operational reliability remains important after a first half hit by a series of challenges. Other risks include the milk price and the cost of working capital, covenant compliance under the bank facilities, timing and seasonality in a short transitional period.

What to Watch Next

The annual meeting is scheduled for 4 December 2026, and director nominations close at 5.00pm New Zealand time on 3 November 2026. TP26 ends on 31 December 2026, with audited statements to include comparatives for the equivalent prior period. Investors in (ASX:SM1) may also monitor customer volumes, net debt, product mix and any further lender or capital announcements ahead of the first full calendar year in 2027.

Key Insights

Synlait Milk (ASX:SM1) closed FY26 with a reported net loss of $75.4 million, but second-half EBITDA of $42.8 million and net profit after tax of $5.2 million indicate improved operating conditions. Net debt fell to $215.0 million. The shift to a December balance date, the absence of quantitative guidance and the customer transition at The a2 Milk Company are the main factors framing the next reporting period for ASX:SM1.